First nine months 2020 Results Press Release

Operating revenue was 151.2 million euros in the first quarter of 2024, a 25% decrease on the first quarter of 2023, mainly due...

4 min

08/05/2024

Agreement to manufacture pre-filled syringes for a global pharmaceutical company Production will take place on one state-of-the-art...

3 min

25/04/2024

Madrid – 2 April, 2024 – Today, Laboratorios Farmacéuticos Rovi, S.A. (“ROVI” or the “Company”) has announced that the U.S. Food and Drug...

4 min

02/04/2024

Download our press release published on 5 November to find out the financial results for the first nine months of 2020.